Intratympanic ciprofloxacin and the human labyrinthine sampling model

Laryngoscope. 2002 Apr;112(4):686-8. doi: 10.1097/00005537-200204000-00017.

Abstract

Objective: The aim of the study was to investigate the potential absorption of intratympanic ciprofloxacin through the human round window membrane.

Study design: A prospective study.

Methods: Ciprofloxacin was instilled into the middle ear of 10 patients undergoing acoustic tumor removal. The lateral semicircular canal and vestibule were subsequently opened and, using a microsyringe, labyrinthine fluid was aspirated. A sample each of serum and cerebrospinal fluid was also drawn.

Results: Into each middle ear, 0.5 mL ciprofloxacin (0.3%) was instilled. The time interval between the ciprofloxacin application to the round window membrane and sampling of labyrinthine fluid and plasma ranged from 9 to 120 minutes. There was no measurable ciprofloxacin in the labyrinthine fluid, cerebrospinal fluid, or serum of 10 patients.

Conclusion: The lack of measurable absorption of intratympanic ciprofloxacin into the inner ear indicates that the chance of ototoxicity when ciprofloxacin is used clinically, even in the presence of a tympanic membrane perforation, is low.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / pharmacokinetics*
  • Ciprofloxacin / administration & dosage
  • Ciprofloxacin / pharmacokinetics*
  • Ear, Inner / metabolism
  • Female
  • Humans
  • Labyrinthine Fluids / chemistry
  • Male
  • Prospective Studies
  • Round Window, Ear
  • Tympanic Membrane

Substances

  • Anti-Infective Agents
  • Ciprofloxacin